Is antibiotic prophylaxis able to prevent early death in myeloma?

Dr Stella Bowcock discusses the results of the Tackling Early Morbidity and Mortality in Myeloma (TEAMM) trial and the use of antibiotic prophylaxis in improving patient outcomes in newly diagnosed patients.

The views expressed in this video are those of the speaker.

UK/NP/1806/0035j - August 2018

You are now leaving the Myeloma Hub

This link opens another website that is not under the review or control of Takeda UK Ltd and, as such, the company does not endorse the content, its accuracy, or any practices or standards contained within it. Please confirm you wish to continue.